Content about Rheumatoid arthritis

May 11, 2011
UCB’s Cimzia improves rheumatoid arthritis condition among patients in study

Patients with moderate to severe rheumatoid arthritis who respond to 12 weeks of treatment with a drug made by UCB are more likely to show improvement in their condition in the long run, according to results of a study published in the Journal of Rheumatology.

April 14, 2011
FDA: Certain TNF blockers could be linked to rare cancer

The Food and Drug Administration has received reports of a rare and usually deadly cancer in patients using a class of biotech drugs to treat autoimmune and inflammatory diseases, the agency said Thursday.

March 21, 2011
Nature's Health Connection's Australian Dream achieves record sales

Nature's Health Connection said its over-the-counter pain-relief cream has garnered record retail sales.

March 3, 2011
Amneal receives FDA approval for generic Indocin

The Food and Drug Administration has approved a generic drug for pain and inflammatory diseases made by Amneal Pharmaceuticals, Amneal said Thursday.

January 6, 2011
Genentech granted supplemental approval for Actemra

The Food and Drug Administration has expanded the approved usage of a drug made by Genentech, part of Swiss drug maker Roche.

December 7, 2010
Bristol-Myers Squibb seeks additional approval for Orencia

The Food and Drug Administration has accepted for review a supplemental approval application for an arthritis drug made by Bristol-Myers Squibb, the drug maker said Monday.

November 7, 2010
RA patients may benefit from weekly injection of Orencia, study finds

Patients with rheumatoid arthritis derive about as much benefit from a weekly injection of a...

September 29, 2010
Centocor Ortho Biotech seeks expanded approval for Simponi

The biotech division of Johnson & Johnson is hoping to expand the use of a...

July 22, 2010
Horizon Pharma unveils Lodotra trial

An investigational drug for rheumatoid arthritis reduced the duration of symptoms in patients over the...

July 13, 2010
Mylan's generic arthritis drug receives FDA approval

The Food and Drug Administration has approved a generic arthritis treatment made by Mylan, the...

June 27, 2010
Gilead to acquire CGI

Gilead Sciences plans to acquire a development-stage pharmaceutical company for up to $120 million, Gilead...

June 15, 2010
Horizon: Lodotra reduces RA symptoms in patients in trial

An investigational drug for rheumatoid arthritis significantly reduced symptoms in patients, according to results of...

May 24, 2010
Report: Teva recruits patients for Rituxan biosimilar trial

Generic drug maker Teva Pharmaceutical Industries isn’t holding back in its effort to push into...

May 18, 2010
Genentech receives FDA approval for Actemra

The Food and Drug Administration has approved a new biotech drug made by Roche U.S....

May 12, 2010
Abbott presents home-improvement tool for RA patients

To recognize National Arthritis Awareness Month, Abbott is highlighting a resource that seeks to help...

May 2, 2010
FDA approves Vimovo

The Food and Drug Administration has approved a drug by AstraZeneca and Pozen for treating...

March 7, 2010
Roche, Biogen Idec halt ocrelizumab trials

Roche and Biogen Idec are suspending trials of a drug for treating autoimmune disorders amid...

February 16, 2010
Drug makers sign agreement to develop rheumatoid arthritis drug

Anglo-Swedish drug maker AstraZeneca and American drug maker Rigel Pharmaceuticals have signed a global licensing...

January 10, 2010
FDA approves Genentech's new rheumatoid arthritis treatment

The Food and Drug Administration has approved a Genentech drug for treating rheumatoid arthritis, the...

© 2013 Drug Store News. All Rights Reserved.